Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Gradientech logo — Precision medicine for a sustainable world.

Gradientech

Precision medicine for a sustainable world.

Founded 2009 Sweden Sweden 42 employees Venture round Total: $34.67M Biotechnology, Health Care +1

General Information

Company Name Gradientech
Founded Year 2009
Location Sweden Sweden
Employees 42
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Gradientech. To contact Gradientech, visit gradientech.se.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Gradientech compare?

A PDF of Gradientech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Gradientech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Gradientech

Gradientech is a Swedish in vitro diagnostics company founded in 2009 that focuses on precision medicine for a sustainable world. The company's flagship product, QuickMIC®, is aimed at supporting modern microbiology labs by providing ultra-rapid antibiotic susceptibility testing (AST) for time-critical samples such as positive blood culture samples from sepsis patients. This scalable system, with each instrument analyzing one sample against a tailored gram-negative antibiotic panel, can deliver MIC values in as short as 2 hours, making it faster than any other diagnostic system for phenotypic AST. Gradientech's technology, which integrates microfluidics with live imaging to analyze bacterial responses on a linear antibiotic concentration gradient, provides MIC values with unprecedented precision in record time. The company operates within the Biotechnology and Health Care industries, with headquarters in Sweden. In April 2019, Gradientech secured a $4.60M Venture Round investment, demonstrating investor confidence in the company's innovative solutions for rapid and precise AST in complex clinical scenarios.

Business keywords: Precision medicine, Biotech, Diagnostics, Microbiology, Antibiotic susceptibility testing, Medical technology, Sepsis, Blood culture samples, Microfluidics, Live cell imaging, ISO13485 certification

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $4.60M -
04 Apr 2019
Venture Round kr20.00M 1
Almi Invest
Almi Invest
13 Sep 2018
Grant €71.43K 1
EASME - EU Executive Agency for SMEs
01 Apr 2018
Venture Round kr10.00M 1
CBC Investment Group AB
CBC Investment Group AB
09 Dec 2016
Venture Round Undisclosed 1
Almi Invest
Almi Invest
01 Jan 2011

Gradientech Alternatives & Competitors

View All Alternatives
Gradientech vs
Pathnostics - A Diagnostics Solutions Company
Pathnostics - A Diagnostics Solutions Company United States

We pioneer approaches for better patient care and empower physicians to champion patient health toda...

Private Equity
171 employees
Biotechnology, Health Care
Compare Gradientech vs Pathnostics - A Diagnostics Solutions Company
Gradientech vs
Pattern Bioscience
Pattern Bioscience United States

Our mission is simple: We will improve the world's most important health decisions.

Series C
76 employees
Biotechnology, Health Care
Compare Gradientech vs Pattern Bioscience
Gradientech vs
Ativa
Ativa United States

Decoding Blood, Changing Care.

Venture round
20 employees
Biotechnology, Health Care
View all alternatives

FAQ About Gradientech

Precision medicine for a sustainable world.
Gradientech was founded in 2009.
Gradientech is headquartered in Sweden.
Gradientech operates in Biotechnology, Health Care and Life Sciences. Its work centres on Precision medicine, Biotech, Diagnostics and Microbiology.
Gradientech has approximately 42 employees.
Gradientech has completed 5 funding rounds, raising a total of $34.67M. The latest funding stage is Venture round.
Top alternatives and competitors to Gradientech include Pathnostics - A Diagnostics Solutions Company, Pattern Bioscience, Ativa, ALIFAX, First Light Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Gradientech and Pathnostics - A Diagnostics Solutions Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Gradientech, https://bouncewatch.com/company/gradientech, updated 10 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout